299 related articles for article (PubMed ID: 5451178)
21. [Advances and principles in tuberculostatic therapy].
Bethge H
Internist (Berl); 1971 Aug; 12(8):328-31. PubMed ID: 4328130
[No Abstract] [Full Text] [Related]
22. Gitelman-like Syndrome with Kanamycin Toxicity.
Santra G; Paul R; Karak A; Mukhopadhay S
J Assoc Physicians India; 2016 May; 64(5):90-92. PubMed ID: 27735167
[TBL] [Abstract][Full Text] [Related]
23. Treatment of patients with drug-resistance in economically developed countries.
Crofton J
Tubercle; 1969 Mar; 50():Suppl:65-8. PubMed ID: 4319134
[No Abstract] [Full Text] [Related]
24. [Capreomycin in the combination treatment of chronic pulmonary tuberculosis].
Sighart H; Opl G
Prax Pneumol; 1970 Jan; 24(1):15-20. PubMed ID: 4984503
[No Abstract] [Full Text] [Related]
25. [Evaluation of the therapeutic effects of secondary antitubercular agents].
Watanabe S; Nosaki M; Iwasaki M; Hamano S; Furuya Y
Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119
[No Abstract] [Full Text] [Related]
26. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
Kam KM; Yip CW
Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
[TBL] [Abstract][Full Text] [Related]
27. Ethambytol in the retreatment of pulmonary tuberculosis. United States Public Health Service cooperative trial.
Steininger WJ
Bull Int Union Tuberc; 1968 Dec; 41():181-2. PubMed ID: 4303861
[No Abstract] [Full Text] [Related]
28. [Efficiency of interrupted therapy of tuberculosis (experimental study)].
Drabkina RO; Ginzburg TS
Antibiotiki; 1972 Jun; 17(6):555-60. PubMed ID: 5045922
[No Abstract] [Full Text] [Related]
29. Experimental studies on therapeutic effects of various combinations of antituberculosis drugs. I. Comparison of various regimens in treatment of experimental mouse tuberculosis infected with drug-susceptible mycobacteria.
Hokama S
Jpn J Tuberc; 1967 Jul; 14(1):29-44. PubMed ID: 5300097
[No Abstract] [Full Text] [Related]
30. [Autonomous treatment of pulmonary tuberculosis with delayed-action drugs].
Pannain M; Tarantino AB; Mac Dowell A; Costa JA; Cunha JM; Pantoja W
Rev Bras Med; 1967 Aug; 24(8):664-8. PubMed ID: 5603007
[No Abstract] [Full Text] [Related]
31. [Autonomic drug therapy with delayed action drugs in pulmonary tuberculosis (chronic-drug therapy resistant patients, without immediate surgical possibilities)].
Bethlem N; Mendes W
Hospital (Rio J); 1968 Jul; 74(1):1-5. PubMed ID: 5305552
[No Abstract] [Full Text] [Related]
32. [Treatment with secondary antitubercular agents].
Ovreberg K
Tidsskr Nor Laegeforen; 1968 May; 88(9):741-9. PubMed ID: 4298856
[No Abstract] [Full Text] [Related]
33. [Clinical problems of resistance to secondary antitubercular agents].
Baba H; Takahashi R; Nakai T; Torii R; Yo I
Iryo; 1966 Mar; 20(3):230-40. PubMed ID: 5964830
[No Abstract] [Full Text] [Related]
34. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
Grumbach F
Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543
[No Abstract] [Full Text] [Related]
35. CHEMOTHERAPY REGIMENS USED IN RETREATMENT OF PULMONARY TUBERCULOSIS. II. OBSERVATIONS ON THE EFFICACY OF COMBINATIONS OF ETHAMBUTOL, CAPREOMYCIN AND COMPANION DRUGS, INCLUDING 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE.
KASS I
Tubercle; 1965 Jun; 46():166-77. PubMed ID: 14327964
[No Abstract] [Full Text] [Related]
36. [Effect of the addition of the 3rd agent on the combined therapy with ethionamide and kanamycin in tuberculosis in the mice].
Matsumiya T; Freerksen E; Rosenfeld M
Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):30-4. PubMed ID: 4991617
[No Abstract] [Full Text] [Related]
37. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
Bignall JR
Bull Int Union Tuberc; 1968 Dec; 41():175-7. PubMed ID: 4885379
[No Abstract] [Full Text] [Related]
38. [Observations on antituberculous drug-resistance among pulmonary tuberculosis patients at the National Sanatoria in Kyushu district. 3. The secondary anti-tuberculosis agents (kanamycin, cycloserine, ethionamide)].
Yamaguchi S
Iryo; 1968 Oct; 22(10):1115-9. PubMed ID: 5715475
[No Abstract] [Full Text] [Related]
39. [Therapeutic effects of secondary antitubercular agents at our hospital].
Nakayama K; Hayashida M; Ishihara M; Ijichi F; Obata Y
Iryo; 1966 Mar; 20(3):257-63. PubMed ID: 5964832
[No Abstract] [Full Text] [Related]
40. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
Utkin VV; Rudoĭ NM
Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
